Kyung-Hyun Min

Title: Kyung-Hyun Min: Innovator in Central Nervous System Treatments

Introduction

Kyung-Hyun Min is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds for treating central nervous system disorders. With a total of 3 patents, his work focuses on innovative solutions for mental health issues.

Latest Patents

Kyung-Hyun Min's latest patents include the development of 3 or 4-substituted piperidine compounds. These compounds are disclosed as racemic or enantiomerically enriched forms, represented by a specific structural formula. They are designed to be used in pharmaceutical compositions for treating diseases of the central nervous system, including depression, anxiety, and pain disorders. Another significant patent involves 3-substituted propanamine compounds, which also serve similar therapeutic purposes. These compounds are presented as racemic or enantiomerically enriched forms and are intended for use in pharmaceutical compositions targeting central nervous system diseases.

Career Highlights

Kyung-Hyun Min is currently associated with Sk Biopharmaceuticals Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments for mental health conditions, showcasing his commitment to improving patient outcomes.

Collaborations

Throughout his career, Kyung-Hyun Min has collaborated with notable colleagues, including Chun-Eung Park and Yong-Je Shin. These partnerships have contributed to the development of his innovative compounds and have enhanced the research efforts at Sk Biopharmaceuticals.

Conclusion

Kyung-Hyun Min stands out as a key figure in the pharmaceutical industry, particularly in the realm of central nervous system treatments. His patents reflect a dedication to addressing critical health issues, and his work continues to impact the field positively.